Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L1044
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | -0.27 | |||||
Debt-to-Equity | -3.26 | |||||
Debt-to-EBITDA | -0.44 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -45.64 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -84.6 | |||||
3-Year EBITDA Growth Rate | 78 | |||||
3-Year EPS without NRI Growth Rate | 78.2 | |||||
3-Year FCF Growth Rate | 78.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 66.91 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 71.19 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.44 | |||||
9-Day RSI | 15.43 | |||||
14-Day RSI | 18.05 | |||||
6-1 Month Momentum % | -41.28 | |||||
12-1 Month Momentum % | -66.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 126.86 | |||||
Days Sales Outstanding | 69.22 | |||||
Days Payable | 45.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.9 | |||||
Shareholder Yield % | -89.15 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -86.96 | |||||
Operating Margin % | -594.5 | |||||
Net Margin % | -673.67 | |||||
FCF Margin % | -611 | |||||
ROA % | -149.25 | |||||
ROIC % | -83.85 | |||||
3-Year ROIIC % | -22.25 | |||||
ROC (Joel Greenblatt) % | -454.69 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.72 | |||||
EV-to-EBIT | -0.71 | |||||
EV-to-Forward-EBIT | -1.06 | |||||
EV-to-EBITDA | -0.72 | |||||
EV-to-Revenue | 4.38 | |||||
EV-to-Forward-Revenue | 1.78 | |||||
EV-to-FCF | -0.72 | |||||
Price-to-Median-PS-Value | 0.06 | |||||
Earnings Yield (Greenblatt) % | -140.85 | |||||
FCF Yield % | -285.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TTOO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 7.164 | ||
EPS (TTM) ($) | -9.298 | ||
Beta | 13.17 | ||
Volatility % | 148.89 | ||
14-Day RSI | 18.05 | ||
14-Day ATR ($) | 0.171639 | ||
20-Day SMA ($) | 1.4108 | ||
12-1 Month Momentum % | -66.67 | ||
52-Week Range ($) | 0.87 - 8.3799 | ||
Shares Outstanding (Mil) | 17.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
T2 Biosystems Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(TTOO)'s stock price today?
When is next earnings date of T2 Biosystems Inc(TTOO)?
Does T2 Biosystems Inc(TTOO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |